Skip to main navigation

albireo_logo_nav.svg

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact
  • Programs
    • Pipeline
    • A4250
    • A3384
    • Elobixibat
    • Nonalcoholic Steatohepatitis (NASH)
  • Science
    • Bile Acids and IBAT Inhibition
    • Publications
  • Patients & Families
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • Nonalcoholic Steatohepatitis (NASH)
    • Chronic (Idiopathic) Constipation
    • Bile Acid Malabsorption (BAM)
  • Media & Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • 2018 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings

Quarterly Reports

Financials menu

  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Reports
    • Key Ratios

Stock Information menu

  • Stock Information

governance menu

  • Corporate Governance
Show all

2018

Q4
  • Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update
  • Albireo Provides Fourth Quarter 2018 Business Update
  • Form 10-K
Q3
  • Albireo Reports Third Quarter 2018 Financial Results
  • Albireo Provides Third Quarter 2018 Business Update
  • Form 10-Q
Q2
  • Albireo Reports Second Quarter 2018 Financial Results
  • Albireo Provides Second Quarter 2018 Business Update
  • Form 10-Q
Q1
  • Albireo Provides First Quarter 2018 Business Update
  • Form 10-Q
  • Albireo Provides First Quarter 2018 Business Update

2017

Q4
  • Albireo Reports Fourth Quarter and Year-End 2017 Financial Results
  • Albireo Pharma Fourth Quarter and Year-End 2017 Financial Results Call
  • Form 10-K
Q3
  • Albireo Reports Third Quarter 2017 Financial Results
  • Form 10-Q
Q2
  • Albireo Reports Second Quarter 2017 Financial Results
  • Form 10-Q
Q1
  • Albireo Reports First Quarter 2017 Financial Results
  • Form 10-Q

2016

Q4
  • Albireo Reports 2016 Financial Results
  • Albireo Pharma Fiscal Year 2016 Earnings Call
  • Form 10-K

Shareholder Tools

  • Printed Materials

    Printed Materials
  • Email Alerts

    Email Alerts
  • Downloads

    Downloads
  • RSS

    RSS
  • Print

    Print
  • Share

    Share

    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS
 
albireo-white

© 2018 Albireo Pharma, Inc.

Contact |  Terms of Use  |  Privacy Policy      twitter